Antifungal therapy Faecal microbiota transplantation Carbapenem resistance Coronavirus disease 2019 Diagnosis Bioavailability Environment Glycopep- tides Digestive colonization Intensive Care Units AT 2 receptors Acinetobacter pittii Cystic fibrosis Catalase Benin Lebanon Mycobacterium ulcerans Bacterial dissemination Aspergillus ESKAPE pathogens AT2R Nosocomial infection Analgesia Humans Food Atypical/etiology/epidemiology/therapy Epithelial cell Geospatial model Arenicin Acinetobacter calcoaceticus–Acinetobacter baumannii complex Biological action Animals EDTA Genomic analysis Elderly patient Heat shock proteins Genotyping Cerebral epidural empyema Filamentous fungi EtCO2 Genetic diversity Bartonella henselae Earlier appropriate treatment Chilblain Carbapenem-resistant bacteria Extra-hospital reservoirs Carvacrol Bloodstream infections 16S rDNA gene sequencing De-escalation Critical care Experimental infections Cinnamaldehyde Biofilms Outcome Cat Scratch Disease Antibiotic resistance Bacteria Antimicrobial Drug development Cassette promoter Cutaneous manifestations Manuscript word count 598 Figure count 1 Carbapenem-producing Enterobacteriaceae Colonization pressure Antibody Congo Brazzaville Mycolactone Carbapenemase-producing Enterobacterales ArfGAP1 Bla NDM-1 Defense mechanisms Arf1 COVID-19 Case report Hand hygiene Hospital-acquired infections Comorbidity Acinetobacter baumannii Aged Bénin Escherichia coli Antimicrobial combinations Acinetobacter spp Synergy Africa Antimicrobial peptides Clonal complex II Buruli ulcer Mechanical ventilation Extended-spectrum-beta-lactamase Bla Oxa-72 Glycerol monolaurate Emerging or re-emerging diseases High-content screening Cross-transmission Environmental reservoir Colistin Acral lesions DRG neurons Gram-negative bacteria